Background: Tattoo ink safety is one of the main concerns surrounding tattooing practices. In order to better assess the risks and increase the safety of tattoo inks, it is important to know about the habits of tattooists in real life. Objective: We investigated the most popular inks in the French market and how professional tattooists used them in their daily practice. Methods: We performed an observational, self-reported, online survey concerning the French tattoo artists. All active professional tattooists in France were invited to take part in a six-question Internet survey regarding their tattoo inks usage habits. Results: 598 tattooists reported 36 different brands of black inks and 30 of colored inks. However, 6 brands of black inks were used by 14.2–44% of the tattooists and, for colored inks, 5 manufacturers were favored by 11.2 up to 55.7% of the tattooists. The majority of tattooists (68.9%) mixed two different colors or more to obtain a new shade while 21.7% would try to find the adequate shade within the assortment provided by a manufacturer. 54.4% had between 10 and 40 references, 31.9% had less than 10 references, 11.5% had 40–100 references, and 2.2% had >100 references. Conclusions: The market of tattoo inks in France is dominated only by a fistful of brands. Controls by official authorities should target those popular brands, even though all brands should respect the law. Toxicological studies should always precise the provenance market and which brands are tested, so we can assess their impact in real life. Tattooists should also try to lower the number of ready-made colors they require.

1.
Nho
SW
,
Kim
M
,
Kweon
O
,
Kim
SJ
,
Moon
MS
,
Periz
G
,
Microbial contamination of tattoo and permanent makeup inks marketed in the US: a follow-up study
.
Lett Appl Microbiol
.
2020 Oct
;
71
(
4
):
351
8
. .
2.
Bäumler
W
.
Chemical hazard of tattoo colorants
.
Presse Med
.
2020 Dec
;
49
(
4
):
104046
.
3.
Giulbudagian
M
,
Schreiver
I
,
Singh
AV
,
Laux
P
,
Luch
A
.
Safety of tattoos and permanent make-up: a regulatory view
.
Arch Toxicol
.
2020 Feb
;
94
(
2
):
357
69
. .
4.
ECHA
.
Registry of restriction intentions until outcome
.
2022
. Available from: https://echa.europa.eu/fi/registry-of-restriction-intentions/-/dislist/details/0b0236e180dff62a.
5.
Forte
G
,
Petrucci
F
,
Cristaudo
A
,
Bocca
B
.
Market survey on toxic metals contained in tattoo inks
.
Sci Total Environ
.
2009 Nov 15
;
407
(
23
):
5997
6002
. .
6.
Regensburger
J
,
Lehner
K
,
Maisch
T
,
Vasold
R
,
Santarelli
F
,
Engel
E
,
Tattoo inks contain polycyclic aromatic hydrocarbons that additionally generate deleterious singlet oxygen
.
Exp Dermatol
.
2010 Aug
;
19
(
8
):
e275
81
. .
7.
Liszewski
W
,
Warshaw
EM
.
Pigments in American tattoo inks and their propensity to elicit allergic contact dermatitis
.
J Am Acad Dermatol
.
2019 Aug
;
81
(
2
):
379
85
. .
8.
Kluger
N
,
Bruel
C
,
Beauvois
A
.
Current legislation on tattooing in France
.
Presse Med
.
2020 Dec
;
49
(
4
):
104058
. .
9.
UFC-QUE CHOISIR
.
Encres de tatouage. Face au danger, l’UFC-Que Choisir saisit la DGCCRF
.
18 Feb 2021
. Available from: https://www.quechoisir.org/action-ufc-que-choisir-encres-de-tatouage-face-au-danger-l-ufc-que-choisir-saisit-la-dgccrf-n88486/ (accessed April 08, 2021).
10.
Karbowska
B
,
Rębiś
T
,
Zembrzuska
J
,
Nadolska
K
.
Thallium in color tattoo inks: risk associated with tattooing
.
Med Pr
.
2020 Jul 24
;
71
(
4
):
405
11
. .
11.
Desmedt
B
,
Vanhamme
M
,
Deconinck
E
.
The purity of tattoo inks, screening substances of high concern
.
Regul Toxicol Pharmacol
.
2022 Jan 19
;
129
:
105123
. .
12.
Wang
X
,
Josefsson
L
,
Meschnark
S
,
Lind
ML
,
Emmer
Å
,
Goessler
W
,
Analytical survey of tattoo inks-A chemical and legal perspective with focus on sensitizing substances
.
Contact Dermatitis
.
2021 Sep
;
85
(
3
):
340
53
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.